BioSig Technologies, Inc. (BSGM)

BioSig Technologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	0.19	0.36	11.66	28.27	12.11
Short-Term Investments	0.1	0.1	0	0	0
Cash & Cash Equivalents	0.29	0.46	11.66	28.27	12.11
Cash Growth	-36.03%	-96.07%	-58.76%	133.45%	172.09%
Receivables	0.02	0.01	0	0	0
Inventory	-0.1	0.34	1.88	0.77	0.58
Other Current Assets	0.31	0.33	0.35	0.3	0.14
Total Current Assets	0.53	1.13	13.89	29.34	12.83
Property, Plant & Equipment	0.94	1.49	1.26	0.6	0.89
Long-Term Investments	0.02	-0.1	0	0	0
Intangible Assets	0.29	0.31	0.33	0.35	0.37
Other Long-Term Assets	0.03	1.28	0.04	0.11	0.13
Total Long-Term Assets	1.27	2.98	1.63	1.05	1.39
Total Assets	1.8	4.11	15.52	30.39	14.22
Accounts Payable	0	0	0	0.03	0.35
Deferred Revenue	0.02	0.01	0.03	-0.03	-0.35
Current Debt	0.35	0.31	0.28	0.31	0.41
Other Current Liabilities	4.22	2.94	2.26	4.8	1.62
Total Current Liabilities	4.58	3.26	2.58	5.11	2.03
Long-Term Debt	0.1	0.45	0.37	0	0.31
Other Long-Term Liabilities	0	0	0.01	0	0
Total Long-Term Liabilities	0.1	0.45	0.38	0	0.31
Total Liabilities	4.69	3.71	2.95	5.11	2.34
Total Debt	0.45	0.77	0.66	0.31	0.72
Debt Growth	-40.92%	16.62%	108.92%	-56.60%	-
Common Stock	0.01	0.06	0.04	0.03	0.02
Retained Earnings	-245.02	-215.97	-188.92	-157.01	-104.79
Comprehensive Income	-0.11	-0	0	0	0
Shareholders' Equity	-2.91	0.42	12.35	24.48	11.36
Total Liabilities and Equity	1.8	4.11	15.52	30.39	14.22
Net Cash / Debt	-0.16	-0.31	11	27.95	11.39
Net Cash / Debt Growth	-	-	-60.64%	145.53%	155.84%
Net Cash Per Share	-0.02	-0.07	3.28	10.02	5.50
Working Capital	-4.05	-2.13	11.32	24.23	10.8
Book Value Per Share	-0.40	0.10	3.68	8.77	5.49

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.